Atlas Trials

Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

Clinical trial NCT07226453 · RECRUITING

Trial details

NCT number
NCT07226453
Sponsor
University of California, San Francisco
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Posterior Fossa Ependymal Tumor
Start date
2026-05-05
Primary completion
2028-04-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.